← Back to Search

Behavioral Intervention

Autism-adapted Group Cognitive Behavioral Therapy for Autism Spectrum Disorder

N/A

Waitlist Available

Led By Jessica M Schwartzman, PhD

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 6 months

Awards & highlights

Study Summary

This trial found that an autism-adapted group cognitive-behavioral treatment was feasible and acceptable for autistic adolescents, and had preliminary efficacy in treating depression.

Eligible Conditions

Autism Spectrum Disorder
Suicidal Thoughts
Autism
Depression
Self-Esteem

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Severity of adolescent depressive symptoms, parent-report

Severity of adolescent depressive symptoms, self-report

Trial Design

1Treatment groups

Experimental Treatment

Group I: Autism-adapted Group Cognitive Behavioral TherapyExperimental Treatment1 Intervention

Autistic adolescents (11-17 years old; middle and high school) with depression will participate in a 12-week group intervention, autism-adapted Cognitive Behavioral Therapy, to increase perception and understanding of self and to decrease the severity of depressive symptoms.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Autism-adapted Group Cognitive Behavioral Therapy

2021

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor

856 Previous Clinical Trials

672,168 Total Patients Enrolled

15 Trials studying Autism Spectrum Disorder

2,486 Patients Enrolled for Autism Spectrum Disorder

Jessica M Schwartzman, PhDPrincipal InvestigatorVanderbilt University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent are individuals qualified to take part in this medical trial?

"This medical trial seeks 32 individuals aged 11 to 17 that are struggling with suicidal thoughts and meet the following criteria: educational level between middle or high school, diagnosis of Autism Spectrum Disorder, higher than average intelligence, willingness to attend sessions at study sites regularly as well as engage in weekly group intervention."

Answered by AI

Are there any available opportunities for participants in this experiment?

"Affirmative. Clinicaltrials.gov documents this clinical trial is currently open for enrollment, with its initial posting on 21 July 2021 and most recent amendment occurring 17 June 2022. This research seeks 32 test subjects from a single site."

Answered by AI

Are adolescents within the age range of 18 to 30 accepted for this clinical investigation?

"This research project aims to enroll patients in the 11-17 age range."

Answered by AI

How many individuals are enrolled in this medical investigation?

"Yes, clinicaltrials.gov suggests that this medical experiment is currently recruiting subjects. This trial was initially posted on July 21st 2021 and recently modified in June 17th 2022. 32 patients are required for the research to be conducted at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Group Depression Treatment for Autistic Youth

Jessica Schwartzman, PhD 2021. "Group Depression Treatment for Autistic Youth". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05430022.